PubMed Health⌕ Search

Biomedical subjects

R J McCarthy

Publications and source records attributed to R J McCarthy.

At least 73 records · Page 4Linked to original sources
PubMed1988

Effects of continuous arteriovenous hemofiltration on cardiopulmonary abnormalities during anesthesia for orthotopic liver transplantation.

Orthotopic liver transplantation (OLT) often involves large blood loss and replacement, as well as administration of large amounts of blood products to correct coagulation defects. Renal free water excretion is often impaired in end-stage liver disease and not responsive to routine diuretic therapy, predisposing these patients to accumulation of extravascular lung water. The effects of the intraoperative use of continuous arteriovenous hemofiltration (CAVH) on cardiopulmonary and oxygen transport variables were studied in ten patients during and 24 hours after OLT. CAVH prevented increases in pulmonary shunt fraction while decreasing PEEP and FIO2 requirements. Pulmonary compliance was significantly higher after operation in patients receiving CAVH. Before surgical dissection, hemodynamic effects of CAVH were minimal. Postoperatively, patients having CAVH had lower cardiac filling pressures and more normal systemic vascular resistance than did patients not having CAVH. These data suggest that CAVH may be a useful intraoperative technique for patients with impaired renal function undergoing liver transplantation.

Adolescent↗
PubMed1988

Treatment of decompression sickness with a perfluorocarbon emulsion (FC-43).

Decompression sickness is caused by the production of tissue and blood stream inert gas bubbles. Perfluorocarbon emulsions (PFC) have enhanced O2 and N2 solubilities as well as a small particle size as properties. The effects of treatment with a PFC (FC-43) and 100% oxygen on decompression sickness were investigated in 24 Sprague-Dawley rats compressed to 6.8 ATA and rapidly decompressed. Survival in animals receiving PFC and 100% oxygen was significantly longer (P = 0.01) than in those receiving a 6% hetastarch (H) treatment. The PFC survivors at 24 h did not demonstrate any neurologic deficits, whereas the 1 H animal surviving at 24 h was ataxic and not eating. Those animals who died most often did so within minutes after decompression, suggesting a hemodynamic demise. We conclude that PFC treatment when coupled with 100% oxygen breathing provides both hemodynamic and neurologic protection from decompression sickness.

Animals↗
PubMed1988

Comparison of continuous epidural infusion of fentanyl-bupivacaine and morphine-bupivacaine in management of postoperative pain.

The short duration of epidural fentanyl has limited its direct comparison with epidural morphine in previous reports. The following study was performed of continuous postoperative epidural infusions at 5 ml/hr fentanyl 10 micrograms/ml (n = 59) or morphine 0.1 mg/ml (n = 48), both with bupivacaine 0.1%, in patients having cesarean sections. Postoperative evaluations included the frequency and magnitude of clinically evident respiratory depression, the adequacy of analgesia, nausea, pruritus, the ability to ambulate, and other side effects for 24 hours. Analgesia and the number of supplemental narcotic injections needed were similar in both groups. The incidence of nausea and pruritus was significantly less in the patients receiving fentanyl. No patient developed respiratory depression in either group. Patient and staff acceptance of the continuous epidural technique was excellent because there were only minor catheter-related problems associated with its use. It is concluded that continuous epidural fentanyl combined with bupivacaine offers excellent postoperative analgesia with minimal side effects.

Bupivacaine↗
PubMed1987

Vasopressor challenges during chronic MAOI or TCA treatment in anesthetized dogs.

Ten male mongrel dogs were treated in Phase I with tranylcypromine, 6 mg/kg IM b.i.d., for 21 days. Dogs were anesthetized at weekly intervals before, during, and up to four weeks after drug treatment with a combination of amylbarbital, 25 mg/kg, 1% enflurane in 70:30 N2O:O2 and fentanyl, 500 mcg. Bolus IV injections of norepinephrine, 0.1-0.6 mcg/kg, and ephedrine, 0.03-0.12 mg/kg were given while continuously recording arterial blood pressure, lead II of the ECG, heart rate, and rectal temperature. Awakening times were noted. In Phase II, the dogs were given imipramine, 25 mg/kg IM b.i.d., for 21 days. During Phase III, 14 days of tranylcypromine, 7 days of tranylcypromine plus imipramine, and 7 days of imipramine were administered. Anesthetic techniques were repeated in phases II and III. The fourth phase consisted of tranylcypromine injections, 6 mg IM b.i.d., and anesthesia with amylbarbital, 25 mg/kg, 2.5% enflurane in 70:30 N2O:O2. Vasopressor challenges were repeated during each phase of the study. Following induction of anesthesia and prior to fentanyl challenge, baseline blood pressures and heart rates did not differ from control in Phase I, II, and III of this study. Responses to norepinephrine during all of the tranylcypromine phases were not significantly different from control but ephedrine responses were prolonged, peaking by the second week of treatment. During Phase II, dysrhythmias occurred following norepinephrine and ephedrine with one lethality following norepinephrine, 0.2 mcg/kg. Responses to norepinephrine and awakening times were significantly greater during Phase II compared to Phase I. In Phase III, during the first week of combined therapy the responses to norepinephrine were significantly greater than any other week of this phase. During Phase IV, resting blood pressure and the ephedrine responses were significantly increased during tranylcypromine when the anesthesia regimen did not include fentanyl. These results suggest that during initial treatment with tranylcypromine or imipramine, cardiovascular responses to vasopressor challenges were predicted by the pharmacology of the antidepressant. During tranylcypromine phases, we did not observe exaggerated cardiovascular effects during anesthesia and vasopressor challenges as had been previously reported.

Anesthetics↗
PubMed1987

Thromboelastography as an indicator of post-cardiopulmonary bypass coagulopathies.

Postoperative hemorrhage in patients undergoing open-heart surgery is a major cause of morbidity and mortality. Monitoring of coagulation in these patients has routinely involved the activated clotting time. Thromboelastography is currently used as a monitor of coagulation during liver transplantation. The thromboelastogram, by providing information on the interaction of all the coagulation precursors, gives more clinically useful information on coagulation than that available from the coagulation profile or the activated clotting time alone. This study was done to assess the usefulness of thromboelastography in open-heart surgery. Thirty-eight patients (29 undergoing coronary artery bypass grafting and 9 undergoing valve replacement) were studied with activated clotting time, thromboelastography, and coagulation profiles during three periods: before bypass, during bypass, and after protamine administration. Thromboelastography was a significantly better predictor (87% accuracy) of postoperative hemorrhage and need for reoperation than was the activated clotting time (30%) or coagulation profile (51%). Thromboelastography is easy to use and provides diagnostic data within 30 minutes of blood sampling.

Blood Coagulation Disorders↗
PubMed1987

Protection from coronary air embolism by a perfluorocarbon emulsion (FC-43).

The protective effects of a perfluorocarbon emulsion (FC-43) against the physiological sequelae of selective coronary air embolism (CAE) were examined in dogs. Animals were randomly assigned to two groups: group 1 received 20 mL/kg of 6% hetastarch in 0.9 normal saline solution with 280 mg/L of CaCl2; group 2 received 20 mL/kg of FC-43 (Oxypherol, Alpha Therapeutic Corp, Los Angeles). Infusion time for both groups was 30 minutes. Following a ten-minute stabilization period, a 0.02-mL/kg bolus of air was injected into the left anterior descending coronary artery distal to the first branch. Surface and epicardial ECGs, systemic BP, pulmonary artery pressure, central venous pressure, left ventricular pressure, left ventricular end-diastolic pressure (LVEDP), dP/dtmax, and Vmax were recorded continuously. Cardiac output (by thermodilution technique), myocardial creatine phosphokinase levels and the lactic acid concentration were measured. The study revealed a significantly lower systemic mean arterial pressure (MAP), LVEDP, left ventricular stroke work index (LVSWI), and right ventricular stroke work index (RVSWI) in the group receiving the FC-43 prior to receiving CAE. Possible causes of the differences are a species-specific direct vasodilating effect of FC-43 or histamine release. Following CAE, myocardial function as measured by dP/dtmax, Vmax, and MAP was lower in group 1 during the first five minutes following CAE. ECG tracings showed all of the ten group 1 dogs had ST-T changes (greater than 2 mm), and six of the ten had ventricular dysrhythmias or conduction defects. Only one of the group 2 dogs showed ST-T wave changes (P = .0006, Fisher's exact test), and none had dysrhythmias (P = .005, Fisher's exact test).(ABSTRACT TRUNCATED AT 250 WORDS)

Animals↗
PubMed1987

The effect of chronic subarachnoid bupivacaine infusion in dogs.

A functional and histologic examination of the effect of the continuous intrathecal administration of bupivacaine was made in five dogs. After a partial laminectomy at L5, a silicone rubber catheter was inserted into the subarachnoid space and advanced 10 cm cranially. A model 400 Infusaid pump, used for drug delivery, was placed in a subcutaneous pocket between the 13th rib and iliac crest. Drug infusions were individually adjusted and maintained at a concentration such that the animal just exhibited slight gait impairment. Daily bupivacaine doses ranged from 5.7-11.1 mg. Infusions were maintained for a period of 3-16 weeks. Light microscopic examination of spinal cord and roots revealed no abnormalities. A focal mononuclear cell infiltration of the leptomeninges was seen in two drug animals, as well as one catheter control animal. One of the 16-week animals had a residual limp upon drug removal. While we were not able to quantitatively assess the degree of sensory motor dissociation, the results of this study suggest that chronic intrathecal bupivacaine infusion through an implantable pump system may be a short-term alternative to intrathecal morphine in the control of cancer pain.

Anesthesia, Spinal↗
PubMed1987

Effects of nitrous oxide on coronary perfusion after coronary air embolism.

Coronary air embolism (CAE) can occur after heart surgery whenever air is present in the left heart or proximal aorta. When CAE occurs, its sequelae can range from electrocardiographic changes of ischemia to severe myocardial dysfunction and cardiac arrest. Since N2O has been shown to have detrimental effects in the presence of coronary obstructions, as well as the tendency to enlarge air emboli, the authors tested the hypotheses that N2O would enhance the deleterious effects of CAE, and that discontinuing N2O at the time of CAE would minimize those effects. The effects of ventilation with and without N2O on the cardiac insult due to left anterior descending CAE (0.02 ml.kg-1) were studied in 27 swine. Global cardiovascular changes that occurred after CAE included decreases in cardiac output, systemic arterial and coronary perfusion pressure, and LV dP/dt, as well as increases in LVEDP. These parameters returned towards baseline over time when N2O was discontinued at the time of CAE. Maintenance of N2O in the inspired gas after CAE occurred was uniformly fatal within 2-4 min in this model. Regional myocardial ischemia was significantly greater in animals receiving N2O, as documented by: 1) a greater incidence of elevations of epicardial ST-segments exceeding 3 mm from baseline in embolized and non-embolized coronary artery distributions, 2) a greater incidence of dysrhythmias (greater than 6 PVCs.min-1), 3) longer duration of depression of coronary blood flow, 4) longer duration of post-ischemic coronary hyperemia, and 5) larger decreases with less recovery over time of regional myocardial lactate extraction.(ABSTRACT TRUNCATED AT 250 WORDS)

Animals↗
PubMed1987

Effects of progressive blood loss on coagulation as measured by thrombelastography.

The effects of progressive blood loss on coagulation were studied in 87 adults (age 23-66 yr) undergoing a variety of operations under general anesthesia. None had preoperative alterations in coagulation or liver function and none were receiving anticoagulant or antiplatelet medication. Whole blood coagulation status was quantitated using thrombelastography (TEG). Blood samples for TEG were obtained 5 min before and 15 min after induction of anesthesia, after each increment of blood loss (EBL) equalling 5% of estimated blood volume (EBV), at the end of surgery, and 2 hr post-operatively. Patients with EBL exceeding 0.15 EBV were given packed red cells and crystalloid solution. Patients with EBL less than 0.15 EBV received only crystalloid. Thrombelastography analysis showed a trend toward increased coagulability with progressive blood loss. Two of four patients with 80% loss of EBV maintained normal to enhanced coagulation status, although the other two developed clinical and thrombelastographic evidence of coagulopathy. Thrombelastography allowed rapid intraoperative diagnosis and specific treatment of loss of platelet activity in the latter two patients. We conclude that during moderate to massive blood loss, use of supplemental fresh frozen plasma and/or platelets should be reserved for patients with documented defects in coagulation. Thrombelastography is useful for the detection and management of coagulation defects associated with intraoperative blood loss.

Adult↗
PubMed1986

Cardiorespiratory effects of venous air embolism in dogs receiving a perfluorocarbon emulsion.

The cardiorespiratory effects of a nonlethal venous air embolism were studied in dogs in the presence of a perfluorocarbon emulsion (PFE). Prior to embolization, five dogs received 20 cc/kg of hydroxyethyl starch (6% HES) and five received PFE oxypherol (20% FC-43). Determinations of mean systemic arterial pressure (MAP), pulmonary artery pressure (PAP), left ventricular pressure (LVP), first and second derivatives of LVP with respect to time (dP/dt and Vmax), cardiac index (CI), stroke index, left and right ventricular stroke work index (LVSWI and RVSWI), PaCO2, PaO2, and venous admixture (Qs/Qt) were made before and then 1, 5, 10, and 30 minutes after placement of the venous air emboli (0.75 cc/kg/min for 5 minutes). After emboli were introduced, PaO2, MAP, LVSWI, dP/dt, Vmax, and CI decreased; the average decrease during the first 5 minutes was significantly less in the PFE group. Following introduction of venous air emboli, PAP, PaCO2, RVSWI, and Qs/Qt increased less in the PFE group than in the HES group, with statistical significance achieved at various times during the first 10 minutes after embolism. All parameters returned toward baseline values by 30 minutes in both groups. This study indicates that FC-43, when administered before venous air embolism, helps to attenuate some of the detrimental cardiorespiratory effects of the embolism.

Animals↗
PubMedDate not supplied

Does the design of the Sprotte spinal needle reduce the force needed to deform the tip?

STUDY OBJECTIVE: To determine whether the window design of pencil-point spinal needles leads to deformation under lateral or axial loading conditions. DESIGN: Independent-measure, multigroup study of the force required to deform needles. SETTING: Independent testing laboratory. MEASUREMENTS AND MAIN RESULTS: The force necessary to bend 22- and 24-gauge Sprotte, 22- and 25-gauge Whitacre, and 22- and 25-gauge Quincke needles was measured using an Instron gauge (Instron Corp., Canton, MA) after microscopic verification of needle uniformity. Effects of lateral and axial forces were evaluated in separate experiments. The force needed to bend the Sprotte needles was less than that needed for the Whitacre and Quincke needles of similar size when lateral or axial pressure was applied. Microscopic inspection of the needles showed a marked variability in the window area placement in a single lot of Sprotte needles. Examination of the needle tips demonstrated that the Sprotte needles were most likely to bend at the needle window, while the Quincke and Whitacre needles deformed at the point of clamping. CONCLUSIONS: The Sprotte needles have an inherent design weakness to lateral and axial pressure, which may result in a greater number of needle tip deformations upon needle insertion. The nature of this deformation may result in difficulty in needle withdrawal and possibly fracture of the needle tip.

Analysis of Variance↗
PubMedDate not supplied

Nerve blocks with 5% butamben suspension for the treatment of chronic pain syndromes.

BACKGROUND AND OBJECTIVES: Butamben is a non-water-soluble local anesthetic that can be prepared as an aqueous suspension for nerve blocks. This report describes the use of 5% butamben suspension for the treatment of chronic pain of cancer and noncancer origin. METHODS: The clinical courses of 75 consecutive patients were analyzed following 5% butamben nerve blocks (35 epidural blocks only, 33 peripheral nerve blocks only, and 7 had both epidural and peripheral nerve blocks). Epidural blocks were performed as a series of four with additional blocks offered if needed. Peripheral nerve blocks were done as a single block with repeat injections if needed. Injection volumes varied between 15 and 25 mL for epidural injections and 5 and 20 mL for peripheral nerve blocks. Successful therapy was defined as a -75% reduction in subjective pain assessments for -4 weeks or until death. Daily opioid requirements were also recorded. RESULTS: Fifty-four of the 75 patients (72%) were successfully treated. This included 48 of 67 cancer patients (71.6%) and 6 of 8 noncancer patients (75%). Median duration of pain relief was 12 weeks (range, 1-96) in the cancer patients and 10 weeks (range, 6-166) in the noncancer patients. Mean reduction in opioid requirements in successfully treated cancer patients was 74+/-5%. Pain on epidural injection occurred in half of the patients and was the most prevalent complication of treatment. Five patients had signs of intravascular injection. There were no serious long-term sequelae. CONCLUSIONS: When used as described in this report, 5% butamben suspension appears to be effective for treatment of chronic pain of both cancer and noncancer origin and has a low incidence of adverse sequelae.

Anesthetics, Local↗
PubMedDate not supplied

Continent jejunal reservoir (Kock pouch) for urinary diversion in dogs.

Urinary diversion by transplantation of both ureters into a reservoir constructed from 60 cm of jejunum was performed in six clinically normal dogs. The reservoir was connected to a stoma on the abdominal wall through a valve constructed from a short segment of intussuscepted bowel to provide continence. The reservoir was emptied three times daily by catheterization. One dog did not survive the surgical procedure and two dogs died within 1 week of surgical complications. The postoperative capacity of the reservoir in surviving dogs was 100 to 200 mL; it increased during the first month to 600 to 750 mL. Continence was excellent in two dogs. One dog was continent until month 2, when partial slippage of the intussusception occurred. A reversible hyponatremic, hypochloremic, hypokalemic metabolic acidosis developed. Bacteriuria was not responsive to systemic or local instillation of antibiotics. Ascending pyelonephritis, hydroureter, and hydronephrosis occurred in two dogs. Struvite urinary calculi formed in one dog. The procedure as described would be unsuitable for clinical use in dogs.

Acidosis↗
PubMedDate not supplied

Deep-frozen allogeneic cancellous bone grafts in 10 dogs: a case series.

Deep-frozen, aseptically collected and processed allogeneic cancellous bone was implanted in eight dogs during the surgical repair of diaphyseal long bone fractures and in two dogs during arthrodeses. A combined allogeneic and autogeneic cancellous bone graft was used in two fractures with a segmental bone loss of more than 5 cm. Bone union occurred in five fractures and in both arthrodeses. Failure of fixation occurred in two dogs with nonunion fractures and in a third dog with an open, infected fracture. Biopsies from the fracture sites were obtained from these dogs following failure of their fracture fixation. The cancellous bone graft appeared to be in the process of normal incorporation in each case. Failure of fixation was attributed to technical or case management errors or both, in each of the three fractures that failed to achieve bony union. Frozen allogeneic cancellous bone grafts were effectively incorporated when used in the primary repair of fractures and arthrodeses. Combined autogenous and allogeneic cancellous bone grafts may be particularly useful in the repair of fractures with large segmental diaphyseal bone defects. The use of allogeneic cancellous bone grafts in nonunion fractures requires further investigation before it can be recommended.

Animals↗
PubMedDate not supplied

Cervical spinal cord compression caused by cryptococcosis in a dog: successful treatment with surgery and fluconazole.

A six-year-old, male Doberman pinscher was presented for acute onset of upper motor neuron tetraparesis. An extradural compressive lesion compatible with intervertebral disk rupture at the sixth to seventh cervical (C6-C7) disk space was evident on myelography. A large, gelatinous mass of pure cryptococcal organisms causing spinal cord compression was identified upon exploratory surgery. Removal of the mass caused relief of clinical signs. No evidence of involvement of other organ systems was found; however, serum and cerebrospinal fluid titers were positive for cryptococcal infection. The dog was treated with fluconazole (5.5 mg/kg body weight, per os sid) until serum titers for cryptococcal infection were negative at seven months postsurgery. To the authors' knowledge, this is the only report of a dog with cryptococcosis treated successfully using fluconazole as a sole agent.

Animals↗